Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Diclofenac potassium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diclofenac potassium and what is the scope of freedom to operate?

Diclofenac potassium
is the generic ingredient in four branded drugs marketed by Depomed Inc, Teva, Sandoz, Novartis, Bionpharma Inc, Watson Labs, Apotex, Mylan, Par Form, and Sun Pharm Inds, and is included in twelve NDAs. There are fourteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Diclofenac potassium has eighty-two patent family members in thirty-six countries.

There are forty-seven drug master file entries for diclofenac potassium. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: diclofenac potassium

Drug Master File Entries: see list47
Suppliers / Packagers: see list21
Bulk Api Vendors: see list34
Clinical Trials: see list312
Patent Applications: see list2,889
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diclofenac potassium at DailyMed

Pharmacology for Ingredient: diclofenac potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
diclofenac potassium
TABLET;ORAL020142-002Nov 24, 1993DISCNNoNo► Subscribe► Subscribe
Depomed Inc
diclofenac potassium
FOR SOLUTION;ORAL022165-001Jun 17, 2009ABRXYesYes8,927,604► Subscribe ► Subscribe
Depomed Inc
diclofenac potassium
CAPSULE;ORAL022202-001Jun 16, 2009ABRXYesYes9,561,200► Subscribe ► Subscribe
Depomed Inc
diclofenac potassium
FOR SOLUTION;ORAL022165-001Jun 17, 2009ABRXYesYes7,482,377► SubscribeYY ► Subscribe
diclofenac potassium
TABLET;ORAL075582-001Feb 23, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus